Skip to main content

Table 2 A commonly used risk group stratification scheme

From: First brachytherapy treatment of prostate cancer in Nigeria using low dose rate radioactive iodine 125

Risk group Clinical stage PSA   Gleason score
Low (0) ≤ T2b AND ≤ 10 AND ≤ 6
Intermediate (1) > T2b OR > 10 OR > 6
High (≥ 2) > T2b AND/OR > 10 AND/OR > 6